Nanjing - Shenzhen - Xianning
JYMed has four peptide API production lines in Nanjing in accordance with FDA cGMP compliance, and two finishing production lines are in Shenzhen.
In addition, we are building up sixteen production lines for peptide API in Xianning, Hubei province, which will be one of the biggest peptide API manufacturing base in China. We provide commercial batches of peptide injectables and freeze-dried powder products under cGMP guidelines.
JYMed can provide Comprehensive Peptide Synthesis Services (CPSS), including our profoundly CRO/CMO/CDMO/OEM and regulatory affairs support.
Zugriffe heute: 2 - gesamt: 1801.